Celerion Establishes Business Presence in Singapore and Appoints Dr Chew Lan Chong as Executive Director

Celerion is pleased to announce the expansion of a formal business presence in Singapore. Heading up the new operations in Singapore is Dr Chew Lan Chong, MBBS, MRCS, MSc as Executive Director, Medical Research. Dr Chong brings 10 years of direct operational experience leading clinical pharmacology units.

Dr Chong will lead Celerion’s business operations in Singapore, provide medical and scientific expertise and collaborate with partner early clinical research units to conduct complex early clinical pharmacology studies to the highest global standards.

“We are delighted to continue to build a strong footprint in Asia with our new office in Singapore, headed up by Chew Lan,” said Frederick Pritchard PhD Vice President of Global Drug Development at Celerion. “The continued expansion in Asia demonstrates Celerion’s commitment to providing clients innovative solutions to conduct patient studies.”

Dr Chong brings to Celerion a wealth of operational experience, having conducted over 130 early clinical studies at organisations including Pfizer and Lilly in Singapore. Dr Chong completed postgraduate medical training through The Royal College of Surgeons in Edinburgh. She received her medical degree from Singapore National University. In 2011, she complemented her medical training and industry experience by earning a Master’s degree in Experimental Therapeutics from The University of Oxford.